Clinical trials
Phase 3 Squamous Cell Carcinoma of Head and Neck trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| All India Institute of Medical Sciences | 1 |
| CEL-SCI Corporation | 1 |
| Cancer Research UK | 1 |
| GlaxoSmithKline | 1 |
| Janssen Research & Development, LLC | 1 |
| Johnson & Johnson Enterprise Innovation Inc. | 1 |
| National Cancer Centre, Singapore | 1 |
| Rakuten Medical, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 10 |
| Head and Neck Neoplasms | 4 |
| Carcinoma, Squamous Cell | 1 |
| Laryngeal Neoplasms | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.